Vertex Pharmaceuticals Inc Revenue per Employee (VRTX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Vertex Pharmaceuticals Inc  (NASDAQ: VRTX)
 

Vertex Pharmaceuticals Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 12.45% in the second quarter 2026, year on year to cumulative value of $12,587 million, Vertex Pharmaceuticals Inc's revenue per employee grew on a trailing twelve months basis to $ 31,079,506. The productivity of Vertex Pharmaceuticals Inc's employees was 0.0%, above the company average.
Within the Healthcare sector Vertex Pharmaceuticals Inc achieved the highest revenue per employee. While Vertex Pharmaceuticals Inc's total ranking has deteriorated compared to the previous quarter from 14 to 28. Vertex Pharmaceuticals Inc has 405 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VRTX Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 12.45 % 7.82 % 9.55 % 10.99 % 12.06 %
Sales per Employee (TTM) $ 31,079,506 30,167,901 29,632,840 28,946,420 28,194,568
VRTX's Total Ranking # 28 # 14 # 101 # 379 # 203
Seq. Revenue Change 11.62 % -6.37 % 3.69 % 3.77 % 7.02 %

VRTX Company Profile >> Back to VRTX Efficiency Comparisons >> Compare VRTX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 1
Overall Market # 28

Revenue per Employee Statistics
High Average Low
$ 30,167,901 $ 14,077,639 $ 1,433,123
(Mar 31 2026)   (Dec. 30, 2014)



Financial Statements
Vertex Pharmaceuticals Inc's Revenue MRQ $ 3,334 Millions Visit VRTX's Income Statement
Vertex Pharmaceuticals Inc's Revenues TTM $ 12,587 Millions Visit VRTX's aggregate revenue growth
What are VRTX's Sales? Visit VRTX's Sales by Segment


  News about Vertex Pharmaceuticals Inc Revenue per employee

Vertex Pharmaceuticals Incorporated has announced a significant breakthrough in pain management with the FD...

Vertex Pharmaceuticals Secures FDA Approval for JOURNAVX, Marks New Revenue Milestone Vertex Pharmaceuticals Incorporated has announced a significant breakthrough in pain management with the FDA s approval of JOURNAVX (suzetrigine), a first-in-class oral, non-opioid treatment for adults experiencing moderate-to-severe acute pain. This innovative medication acts as a highly selective NaV1.8 pain signal inhibitor, addressing a critical need for effective pain relief without the risk of addiction commonly associated with traditional opioid therapies. The FDA s approval signals a pivotal moment not only for Vertex but also for the broader pharmaceutical landscape, as JOURNAVX offers a non-addictive alternative for patients suffering from various forms of acute pain. The medication is now indicated for use across diverse pain conditions, reinforcing Vertex’s commitment to developing novel therapeutic options in the healthcare sector.In parallel with this notable regulatory achievement, Vertex Pharmaceuticals has reported a promising financial performance. The company’s revenue per employee has risen to $1,967,741 on a trailing twelve-month basis, representing an 11.61% increase in revenue for the third quarter of 2024, year-on-year, and bringing the cumulative revenue to an impressive $10,626 million. This achievement marks a new company high, underscoring Vertex s robust growth trajectory amidst evolving market conditions.



Other Ratios
Vertex Pharmaceuticals Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VRTX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VRTX's Competitors
Revenue per Employee for VRTX's Suppliers
Revenue per Employee for VRTX's Customers

You may also want to know
VRTX's Sales Growth Rates VRTX's Pe Price to earnings ratio VRTX's Receivables Turnover Ratio VRTX's Stock Quote
VRTX's Net Income Growth Rates VRTX's Ps Price to Sales ratio VRTX's Sales per Employee VRTX's Asset Turnover Ratio
VRTX's Net Margin VRTX's Pb Price to Book ratio VRTX's Financial Strength Ratios VRTX's Dividend Payout Ratio
Date modified: 2026-09-02T20:09:09+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Vertex Pharmaceuticals Inc  31,079,506.17 $ 12,587.200  Million 405 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.